Video

Improving Vein-to-Vein Time

Source: Cell & Gene

Manufacturing autologous CAR-T products is a complicated process that can take weeks. Luckily, a lot of companies are working to shorten the manufacturing process, and thus, product turnaround or “vein-to-vein” time, in an effort to bring treatment to patients faster. In this segment from the Cell & Gene Live! Event Modernizing CAR-T Manufacturing: Is Point Of Care The Future?, panelists Jason Bock and Tal Salz discuss the biological and technological constraints around autologous CAR-T production.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)